Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
31.67
+0.52 (1.67%)
Jun 8, 2026, 10:48 AM EDT - Market open
Septerna Employees
Septerna had 130 employees as of December 31, 2025. The number of employees increased by 55 or 73.33% compared to the previous year.
Employees
130
Change (1Y)
55
Growth (1Y)
73.33%
Revenue / Employee
$555,808
Profits / Employee
-$277,231
Market Cap
1.43B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 55 | 73.33% |
| Dec 31, 2024 | 75 | - | - |
| Sep 30, 2024 | 73 | - | - |
| Jun 30, 2024 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Vir Biotechnology | 367 |
| KalVista Pharmaceuticals | 275 |
| Monte Rosa Therapeutics | 187 |
| Maze Therapeutics | 141 |
| AnaptysBio | 104 |
| AtaiBeckley | 99 |
SEPN News
- 13 days ago - 3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026 - TipRanks
- 26 days ago - Septerna Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Septerna reports Q1 EPS (19c), consensus (27c) - TheFly
- 27 days ago - Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 27 days ago - Septerna Earnings release: Q1 2026 - Filings
- 27 days ago - Septerna Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Septerna to Present at Bank of America Securities Health Care Conference - GlobeNewsWire
- 5 weeks ago - Septerna initiated with a Buy at Stifel - TheFly